D.E. Shaw & Co’s iShares Biotechnology ETF IBB Stock Holding History

D.E. Shaw & Co’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$65.7M	Buy	389,056 +349,812	+891%	+$59.8M	0.04%	547
2025 Q4	$6.62M	Buy	+39,244	New	+$6.37M	﹤0.01%	2081
2025 Q2	–	Sell	-54,801	Closed	-$7.01M	–	4498
2025 Q1	$7.01M	Buy	+54,801	New	+$7.43M	0.01%	1655
2024 Q4	–	Sell	-45,232	Closed	-$6.59M	–	4589
2024 Q3	$6.59M	Buy	45,232 +28,087	+164%	+$4.06M	0.01%	1737
2024 Q2	$2.35M	Sell	17,145 -58,024	-77%	-$7.75M	﹤0.01%	2515
2024 Q1	$10.3M	Buy	+75,169	New	+$10.3M	0.01%	1337
2020 Q2	–	Sell	-38,250	Closed	-$4.12M	–	4099
2020 Q1	$4.12M	Hold	38,250	–	–	0.01%	1608
2019 Q4	$4.61M	Buy	+38,250	New	+$4.27M	0.01%	1799
2018 Q2	–	Sell	-60,000	Closed	-$6.4M	–	3776
2018 Q1	$6.4M	Buy	+60,000	New	+$6.65M	0.01%	1258
2017 Q1	–	Sell	-24,000	Closed	-$2.12M	–	3427
2016 Q4	$2.12M	Buy	+24,000	New	+$2.18M	﹤0.01%	1949
2016 Q3	–	Sell	-19,167	Closed	-$1.64M	–	3437
2016 Q2	$1.64M	Sell	19,167 -136,533	-88%	-$12.3M	﹤0.01%	2073
2016 Q1	$13.5M	Sell	155,700 -15,933	-9%	-$1.42M	0.02%	698
2015 Q4	$19.4M	Buy	+171,633	New	+$18.6M	0.03%	650
2015 Q3	–	Sell	-65,400	Closed	-$8.04M	–	3795
2015 Q2	$8.04M	Buy	+65,400	New	+$7.83M	0.01%	1150

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

D.E. Shaw & Co's IBB Position: Q1 2026 in Review

D.E. Shaw & Co increased its iShares Biotechnology ETF (IBB) stake by 891% in Q1 2026, buying an estimated $59.8M and bringing the position to 389,056 shares worth $65.7M. The position accounts for 0.04% of the portfolio, ranked #547.

D.E. Shaw & Co first reported a position in IBB in Q2 2015 and has held it in 14 quarters since. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

D.E. Shaw & Co held 389,056 shares of iShares Biotechnology ETF worth $65.7M as of Q1 2026.
D.E. Shaw & Co bought 349,812 iShares Biotechnology ETF shares in Q1 2026, an estimated $59.8M.
iShares Biotechnology ETF made up 0.04% of D.E. Shaw & Co's portfolio in Q1 2026, its #547 holding.
D.E. Shaw & Co first reported a position in iShares Biotechnology ETF in Q2 2015 and has held it in 14 quarters since.
917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.